What treatments are licensed and prescribed by General Practitioners (GPs) for the management of melasma in the United Kingdom (UK)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Licensed Treatments for Melasma Management in the UK

In the UK, there are currently no specifically licensed treatments for melasma, but GPs can prescribe several topical agents that are commonly used for this condition based on clinical guidelines and evidence.

First-Line Treatment Options for GPs

Topical Agents

  • Hydroquinone (4%):

    • Most effective first-line treatment for melasma 1, 2
    • GPs can prescribe as a short-term treatment (typically 2-3 months)
    • Should not be used continuously beyond 6 months due to risk of ochronosis (blue-black discoloration) 1
    • Common side effects include irritation and contact dermatitis
  • Azelaic Acid (15-20%):

    • Alternative to hydroquinone with fewer side effects 1
    • Can be prescribed by GPs for longer-term use
    • Good option for patients who cannot tolerate hydroquinone
  • Topical Retinoids:

    • Tretinoin can be prescribed by GPs
    • Often used in combination with hydroquinone for enhanced efficacy
    • May cause skin irritation, especially in sensitive skin types

Second-Line Treatment Options

Combination Therapies

  • Triple Combination Cream:
    • Contains 4% hydroquinone, 0.05% tretinoin, and 0.01% fluocinolone acetonide
    • Most effective topical treatment with 77-94% of patients achieving clear or almost clear skin 1
    • GPs can prescribe, but typically reserved for resistant cases

Other Topical Agents GPs Can Prescribe

  • Kojic acid - Less irritating alternative to hydroquinone 1, 3
  • Vitamin C preparations - Antioxidant properties that reduce oxidative stress 1
  • Niacinamide - Anti-inflammatory properties helpful for melasma 1, 4

When to Refer to Dermatology

GPs should refer patients to dermatology specialists when:

  1. No improvement after 8-12 weeks of appropriate topical therapy 1
  2. Severe or recalcitrant melasma
  3. Significant adverse effects from first-line treatments
  4. Consideration of advanced treatments is needed

Advanced Treatments (Specialist Only)

  • Chemical Peels:

    • Glycolic acid or salicylic acid peels
    • Typically 3-4 sessions spaced one month apart 1, 5
    • Not typically initiated by GPs
  • Oral Tranexamic Acid:

    • Promising treatment for moderate to severe cases (250mg twice daily)
    • Requires specialist monitoring due to thromboembolic risk 1, 2
    • Not typically initiated by GPs

Critical Adjunctive Measures

  • Sun Protection:
    • Mandatory broad-spectrum SPF 70+ sunscreen 1
    • Inadequate sun protection is the most common reason for treatment failure
    • GPs should emphasize this as essential to any treatment plan

Treatment Monitoring

  • Evaluation every 4-6 weeks using standardized photography 1
  • Assessment using Melasma Area and Severity Index (MASI) score
  • Adjust treatment if no improvement after 8-12 weeks

Common Pitfalls to Avoid

  1. Failing to address hormonal factors: Oral contraceptives or hormone replacement therapy may exacerbate melasma 1

  2. Discontinuing treatment too early: Melasma requires long-term management and maintenance therapy

  3. Aggressive treatments: High-concentration peels or laser treatments can worsen hyperpigmentation, especially in darker skin types 1

  4. Prolonged hydroquinone use: Using hydroquinone continuously beyond 6 months increases risk of ochronosis 1

  5. Inadequate sun protection: This is the most common reason for treatment failure and recurrence 1

References

Guideline

Hyperpigmentation Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Melasma Treatment: An Evidence-Based Review.

American journal of clinical dermatology, 2020

Research

Melasma: treatment strategy.

Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology, 2011

Research

Chemical Peels in Treatment of Melasma.

Dermatologic clinics, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.